Usefulness of MRI in the care of Parkinsonian syndromes

被引：0
|
作者：
Cantin, S.
Krainik, A.
Fraix, V. [1 ]
Savoye, P. -Y.
Tropres, I.
Chabardes, S. [2 ]
Seigneuret, E. [2 ]
Warnking, J. [3 ]
Pinto, S. [4 ]
Grand, S.
Le Bas, J. -F.
Pollak, P. [1 ]
机构：
[1] CHU Grenoble, Clin Univ Neurol, Grenoble, France
[2] CHU Grenoble, Clin Univ Neurochirurg, Grenoble, France
[3] UJF, CEA, CHU, Inst Neurosci,INSERM,U836, Grenoble, France
[4] Univ Aix Marseille, CNRS, UMR6057, Lab Parole & Langage, Marseille, France
来源：
FEUILLETS DE RADIOLOGIE | 2008年 / 48卷 / 05期
关键词：
Parkinsonian syndromes; MRI;
D O I：
10.1016/S0181-9801(08)74462-2
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Parkinsonian syndromes are a major cause of disability in the elderly. MRI has a key role in the management of the patient. Usually normal in Parkinson disease, conventional MRI may show abnormalities related to neurodegenerative diseases (multisystemic atrophy, progressive supra-nuclear palsy...) or secondary to numerous disorders such as hypoxia, metabolic or hereditary diseases. in clinical research, advances MRI techniques including spectroscopy, diffusion and functional MRI provide anatonno-functional and metabolic data useful to investigate pathophysiology.
引用
收藏
页码：291 / 301
页数：11
相关论文
共 50 条
  • [31] Interrelation between Sarcopenia and the Number of Motor Neurons in Patients with Parkinsonian Syndromes
    Krenovsky, Jan-Peter
    Boetzel, Kai
    Ceballos-Baumann, Andres
    Fietzek, Urban M.
    Schoser, Benedikt
    Maetzler, Walter
    Ferrari, Uta
    Drey, Michael
    GERONTOLOGY, 2020, 66 (04) : 409 - 415
  • [32] Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes
    Bech, Sara
    Hjermind, Lena E.
    Salvesen, Lisette
    Nielsen, Jorgen E.
    Heegaard, Niels H. H.
    Jorgensen, Henrik L.
    Rosengren, Lars
    Blennow, Kaj
    Zetterberg, Henrik
    Winge, Kristian
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (01) : 69 - 72
  • [33] Magnetic resonance imaging modalities aid in the differential diagnosis of atypical parkinsonian syndromes
    Tinaz, Sule
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [34] Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts
    Usman Saeed
    Jordana Compagnone
    Richard I. Aviv
    Antonio P. Strafella
    Sandra E. Black
    Anthony E. Lang
    Mario Masellis
    Translational Neurodegeneration, 6
  • [35] The diagnostic value of dopamine transporter imaging and olfactory testing in patients with parkinsonian syndromes
    Charalampos Georgiopoulos
    Anette Davidsson
    Maria Engström
    Elna-Marie Larsson
    Helene Zachrisson
    Nil Dizdar
    Journal of Neurology, 2015, 262 : 2154 - 2163
  • [36] Continuous glucose monitoring can disclose glucose fluctuation in advanced Parkinsonian syndromes
    Todo, Hiroyuki
    NEUROLOGY INTERNATIONAL, 2018, 10 (04) : 107 - 110
  • [37] The diagnostic value of dopamine transporter imaging and olfactory testing in patients with parkinsonian syndromes
    Georgiopoulos, Charalampos
    Davidsson, Anette
    Engstrom, Maria
    Larsson, Elna-Marie
    Zachrisson, Helene
    Dizdar, Nil
    JOURNAL OF NEUROLOGY, 2015, 262 (09) : 2154 - 2163
  • [38] Optimizing the Diagnosis of Parkinsonian Syndromes With 123I-Ioflupane Brain SPECT
    Banks, Kevin P.
    Peacock, Justin G.
    Clemenshaw, Michael N.
    Kuo, Phillip H.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2019, 213 (02) : 243 - 253
  • [39] Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts
    Saeed, Usman
    Compagnone, Jordana
    Aviv, Richard I.
    Strafella, Antonio P.
    Black, Sandra E.
    Lang, Anthony E.
    Masellis, Mario
    TRANSLATIONAL NEURODEGENERATION, 2017, 6
  • [40] Subtle Esophageal Motility Alterations in Parkinsonian Syndromes: Synucleinopathies vs. Tauopathies
    Claus, Inga
    Suttrup, Judith
    Muhle, Paul
    Suntrup-Krueger, Sonja
    Siemer, Marie-Luise
    Lenze, Frank
    Dziewas, Rainer
    Warnecke, Tobias
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2018, 5 (04): : 406 - 412
12345